Alfuzosin

TERMINATED · PHASE3 · Urinary Retention

The study was early terminated due to slow and difficult recruitment

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.